Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2016, Article ID 6815727, 9 pages
http://dx.doi.org/10.1155/2016/6815727
Research Article

Lipoxin A4 Attenuates Cell Invasion by Inhibiting ROS/ERK/MMP Pathway in Pancreatic Cancer

1Department of Hepatobiliary Surgery, First Affiliated Hospital, Xi’an Jiaotong University, Xi’an 710061, China
2Department of General Surgery, First Affiliated Hospital, Xi’an Jiaotong University, Xi’an 710061, China
3Department of General Surgery, Second Affiliated Hospital, Xi’an Jiaotong University, Xi’an 710004, China

Received 21 May 2015; Accepted 27 July 2015

Academic Editor: Amit Tyagi

Copyright © 2016 Liang Zong et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. L. Siegel, K. D. Miller, and A. Jemal, “Cancer statistics, 2015,” CA—A Cancer Journal for Clinicians, vol. 65, no. 1, pp. 5–29, 2015. View at Publisher · View at Google Scholar · View at Scopus
  2. N. B. Janakiram, A. Mohammed, and C. V. Rao, “Role of lipoxins, resolvins, and other bioactive lipids in colon and pancreatic cancer,” Cancer and Metastasis Reviews, vol. 30, no. 3-4, pp. 507–523, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. B. D. Levy, C. B. Clish, B. Schmidt, K. Gronert, and C. N. Serhan, “Lipid mediator class switching during acute inflammation: signals in resolution,” Nature Immunology, vol. 2, no. 7, pp. 612–619, 2001. View at Publisher · View at Google Scholar · View at Scopus
  4. C. N. Serhan, “Pro-resolving lipid mediators are leads for resolution physiology,” Nature, vol. 510, no. 7503, pp. 92–101, 2014. View at Publisher · View at Google Scholar · View at Scopus
  5. H. Hao, M. Liu, P. Wu et al., “Lipoxin A4 and its analog suppress hepatocellular carcinoma via remodeling tumor microenvironment,” Cancer Letters, vol. 309, no. 1, pp. 85–94, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. Y. Chen, H. Hao, S. He et al., “Lipoxin A4 and its analogue suppress the tumor growth of transplanted H22 in mice: the role of antiangiogenesis,” Molecular Cancer Therapeutics, vol. 9, no. 8, pp. 2164–2174, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Nishikawa, “Reactive oxygen species in tumor metastasis,” Cancer Letters, vol. 266, no. 1, pp. 53–59, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. D. J. Lee and S. W. Kang, “Reactive oxygen species and tumor metastasis,” Molecules and Cells, vol. 35, no. 2, pp. 93–98, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Lunardi, R. J. Muschel, and T. B. Brunner, “The stromal compartments in pancreatic cancer: are there any therapeutic targets?” Cancer Letters, vol. 343, no. 2, pp. 147–155, 2014. View at Publisher · View at Google Scholar · View at Scopus
  10. P. Li, Q. Xu, D. Zhang et al., “Upregulated miR-106a plays an oncogenic role in pancreatic cancer,” FEBS Letters, vol. 588, no. 5, pp. 705–712, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. Q. Xu, P. Li, X. Chen et al., “miR-221/222 induces pancreatic cancer progression through the regulation of matrix metalloproteinases,” Oncotarget, vol. 6, no. 16, pp. 14153–14164, 2015. View at Google Scholar
  12. J. Guo, Y. Xu, W. Ji, L. Song, C. Dai, and L. Zhan, “Effects of exposure to benzo[a]pyrene on metastasis of breast cancer are mediated through ROS-ERK-MMP9 axis signaling,” Toxicology Letters, vol. 234, no. 3, pp. 201–210, 2015. View at Publisher · View at Google Scholar
  13. Y. Chen, L. Zheng, J. Liu et al., “Shikonin inhibits prostate cancer cells metastasis by reducing matrix metalloproteinase-2/-9 expression via AKT/mTOR and ROS/ERK1/2 pathways,” International Immunopharmacology, vol. 21, no. 2, pp. 447–455, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. X. Li, Q. Ma, Q. Xu et al., “SDF-1/CXCR4 signaling induces pancreatic cancer cell invasion and epithelial-mesenchymal transition in vitro through non-canonical activation of Hedgehog pathway,” Cancer Letters, vol. 322, no. 2, pp. 169–176, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. K. J. Livak and T. D. Schmittgen, “Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method,” Methods, vol. 25, no. 4, pp. 402–408, 2001. View at Google Scholar
  16. N. Tobar, V. Villar, and J. F. Santibanez, “ROS-NFkappaB mediates TGF-beta1-induced expression of urokinase-type plasminogen activator, matrix metalloproteinase-9 and cell invasion,” Molecular and Cellular Biochemistry, vol. 340, no. 1-2, pp. 195–202, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. V. Nascimento-Silva, M. A. Arruda, C. Barja-Fidalgo, and I. M. Fierro, “Aspirin-triggered lipoxin A4 blocks reactive oxygen species generation in endothelial cells: a novel antioxidative mechanism,” Thrombosis and Haemostasis, vol. 97, no. 1, pp. 88–98, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. E. Börgeson, J. Lönn, I. Bergström et al., “Lipoxin A4 inhibits Porphyromonas gingivalis-induced aggregation and reactive oxygen species production by modulating neutrophil-platelet interaction and CD11b expression,” Infection and Immunity, vol. 79, no. 4, pp. 1489–1497, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. Y. Wu, H. Zhai, Y. Wang et al., “Aspirin-triggered lipoxin A4 attenuates lipopolysaccharide-induced intracellular ROS in BV2 microglia cells by inhibiting the function of NADPH oxidase,” Neurochemical Research, vol. 37, no. 8, pp. 1690–1696, 2012. View at Publisher · View at Google Scholar
  20. C. Neuzillet, P. Hammel, A. Tijeras-Raballand, A. Couvelard, and E. Raymond, “Targeting the Ras-ERK pathway in pancreatic adenocarcinoma,” Cancer and Metastasis Reviews, vol. 32, no. 1-2, pp. 147–162, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. J. Lei, J. Ma, Q. Ma et al., “Hedgehog signaling regulates hypoxia induced epithelial to mesenchymal transition and invasion in pancreatic cancer cells via a ligand-independent manner,” Molecular Cancer, vol. 12, no. 1, article 66, 2013. View at Publisher · View at Google Scholar · View at Scopus
  22. W. Li, L. Cao, L. Han, Q. Xu, and Q. Ma, “Superoxide dismutase promotes the epithelial-mesenchymal transition of pancreatic cancer cells via activation of the H2O2/ERK/NF-kappaB axi,” International Journal of Oncology, vol. 46, no. 6, pp. 2613–2620, 2015. View at Publisher · View at Google Scholar
  23. A. Vincent, J. Herman, R. Schulick, R. H. Hruban, and M. Goggins, “Pancreatic cancer,” The Lancet, vol. 378, no. 9791, pp. 607–620, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. C. F. Wenceslau, C. G. McCarthy, T. Szasz, and R. C. Webb, “Lipoxin A4 mediates aortic contraction via RHOA/RHO kinase, endothelial dysfunction and reactive oxygen species,” Journal of Vascular Research, vol. 51, no. 6, pp. 407–417, 2014. View at Publisher · View at Google Scholar · View at Scopus
  25. D. Nikitovic, E. Corsini, D. Kouretas, A. Tsatsakis, and G. Tzanakakis, “ROS-major mediators of extracellular matrix remodeling during tumor progression,” Food and Chemical Toxicology, vol. 61, pp. 178–186, 2013. View at Publisher · View at Google Scholar · View at Scopus
  26. D. Hanahan and R. A. Weinberg, “Hallmarks of cancer: the next generation,” Cell, vol. 144, no. 5, pp. 646–674, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. M. J. C. Hendrix, E. A. Seftor, D. A. Kirschmann, V. Quaranta, and R. E. B. Seftor, “Remodeling of the microenvironment by aggressive melanoma tumor cells,” Annals of the New York Academy of Sciences, vol. 995, pp. 151–161, 2003. View at Publisher · View at Google Scholar · View at Scopus
  28. L. M. Sander, “Modeling contact guidance and invasion by cancer cells,” Cancer Research, vol. 74, no. 17, pp. 4588–4596, 2014. View at Publisher · View at Google Scholar · View at Scopus
  29. K. Kessenbrock, V. Plaks, and Z. Werb, “Matrix metalloproteinases: regulators of the tumor microenvironment,” Cell, vol. 141, no. 1, pp. 52–67, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. E. Vial and J. Pouysségur, “Regulation of tumor cell motility by ERK mitogen-activated protein kinases,” Annals of the New York Academy of Sciences, vol. 1030, pp. 208–218, 2004. View at Publisher · View at Google Scholar · View at Scopus
  31. B. Poudel, Y. Lee, and D. Kim, “DDR2 inhibition reduces migration and invasion of murine metastatic melanoma cells by suppressing MMP2/9 expression through ERK/NF-κB pathway,” Acta Biochimica et Biophysica Sinica, vol. 47, no. 4, pp. 292–298, 2015. View at Publisher · View at Google Scholar
  32. Y. Xia, S. Lian, P. N. Khoi et al., “Chrysin inhibits tumor promoter-induced MMP-9 expression by blocking AP-1 via suppression of ERK and JNK pathways in gastric cancer cells,” PLoS ONE, vol. 10, no. 4, Article ID e0124007, 2015. View at Publisher · View at Google Scholar
  33. W.-S. Wu, J.-R. Wu, and C.-T. Hu, “Signal cross talks for sustained MAPK activation and cell migration: the potential role of reactive oxygen species,” Cancer and Metastasis Reviews, vol. 27, no. 2, pp. 303–314, 2008. View at Publisher · View at Google Scholar · View at Scopus
  34. J. Lei, X. Huo, W. Duan et al., “α-Mangostin inhibits hypoxia-driven ROS-induced PSC activation and pancreatic cancer cell invasion,” Cancer Letters, vol. 347, no. 1, pp. 129–138, 2014. View at Publisher · View at Google Scholar · View at Scopus